SCHEMBL7857560

SCHEMBL7857560

Cc1noc(NS(=O)(=O)c2cc(F)ccc2F)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 20/20 0.56
EDNRB P24530 15/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7228780 0.85 EDNRB (0.73) EDNRAEDNRB
SCHEMBL7224490 0.76 EDNRA (0.76) EDNRAEDNRB
SCHEMBL7860535 0.76 EDNRA (0.64) EDNRAEDNRB
SCHEMBL7857576 0.75 EDNRA (0.78) EDNRAEDNRB
SCHEMBL7858674 0.74 EDNRB (0.77) EDNRAEDNRB
SCHEMBL24822153 0.74 EDNRA (0.65) EDNRAEDNRB
SCHEMBL30743777 0.74 EDNRA (0.65) EDNRAEDNRB
SCHEMBL7858770 0.74 EDNRA (0.76) EDNRAEDNRB
SCHEMBL27801659 0.74 EDNRA (0.72) EDNRAEDNRB
SCHEMBL7857279 0.73 EDNRA (0.74) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1069114-A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-01-17 EP claimed
EP-0870764-A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1998-10-14 EP claimed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP claimed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO claimed
EP-1069114-A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-01-17 EP disclosed